$21.90
-0.31[-1.40%]
At close: Apr 26
$21.90
0[0.00%]
After Hours: 7:33PM EDT
Corcept Therapeutics
(NASDAQ:CORT)Corcept Therapeutics Stock (NASDAQ:CORT), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/15/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $600.00M | $630.00M | $531.57M | Get Alert |
| 01/08/2024 | CORT | Corcept Therapeutics | Q4 | 2023 | — | — | — | $135.40M | $135.40M | $127.85M | Get Alert |
| 01/08/2024 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $482.40M | $482.40M | $474.82M | Get Alert |
| 01/08/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $600.00M | $630.00M | $513.85M | Get Alert |
| 11/01/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $470.00M | $480.00M | $465.62M | Get Alert |
| 08/02/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $455.00M | $470.00M | $443.89M | Get Alert |
| 05/03/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $435.00M | $455.00M | $435.73M | Get Alert |
| 02/28/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $430.00M | $450.00M | $434.79M | Get Alert |
| 11/03/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $410.00M | $416.67M | Get Alert |
| 08/03/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $414.43M | Get Alert |
| 05/05/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $413.85M | Get Alert |
| 02/15/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $413.19M | Get Alert |
| 11/03/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $365.00M | $375.00M | $371.75M | Get Alert |
| 07/29/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $355.00M | $385.00M | $370.69M | Get Alert |
| 05/06/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $355.00M | $385.00M | $396.20M | Get Alert |
| 02/23/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $375.00M | $405.00M | $398.27M | Get Alert |
| 02/08/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $375.00M | $405.00M | $403.17M | Get Alert |
| 02/08/2021 | CORT | Corcept Therapeutics | FY | 2020 | $0.85 | $0.85 | $0.80 | $353.90M | $353.90M | $358.48M | Get Alert |
| 02/08/2021 | CORT | Corcept Therapeutics | Q4 | 2020 | $0.20 | $0.20 | $0.20 | $85.70M | $85.70M | $96.17M | Get Alert |
FAQ
What is the most recent guidance for Corcept Therapeutics (CORT)?
The last reported Earnings numbers were from February 8, 2021 for the full year 2020 and was for an earnings per share guidance in the range of $0.85 and $0.85 versus the estimated EPS of $0.80.
Browse guidance and forecast on all stocks.